Search

Your search keyword '"Kerr, Keith M"' showing total 728 results

Search Constraints

Start Over You searched for: Author "Kerr, Keith M" Remove constraint Author: "Kerr, Keith M"
728 results on '"Kerr, Keith M"'

Search Results

1. Association between pathologic response and survival after neoadjuvant therapy in lung cancer

2. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

3. ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project

5. The evolution of non-small cell lung cancer metastases in TRACERx

6. The evolution of lung cancer and impact of subclonal selection in TRACERx

11. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

12. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

13. Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists

15. Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project

16. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

28. Adenocarcinoma In Situ

29. Adenocarcinoma, Lung

31. The 2015 World Health Organisation Classification of Lung Cancer

32. Precision Medicine in Lung Cancer

33. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

34. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

37. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

38. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

40. Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists

41. 222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

42. Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

43. Granular Cell Tumor

44. Clear Cell Tumor, Lung

46. Acinic Cell Tumor, Lung

47. Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth

48. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

49. Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort

50. Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists.

Catalog

Books, media, physical & digital resources